COSENTINO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 27.577
EU - Europa 16.554
AS - Asia 10.686
SA - Sud America 1.277
AF - Africa 235
Continente sconosciuto - Info sul continente non disponibili 37
OC - Oceania 28
Totale 56.394
Nazione #
US - Stati Uniti d'America 27.232
IT - Italia 7.613
SG - Singapore 3.421
UA - Ucraina 2.702
CN - Cina 2.389
SE - Svezia 1.576
TR - Turchia 1.523
VN - Vietnam 1.465
HK - Hong Kong 1.110
BR - Brasile 1.105
DE - Germania 896
FI - Finlandia 793
IE - Irlanda 734
GB - Regno Unito 691
FR - Francia 629
RU - Federazione Russa 386
IN - India 215
MX - Messico 163
CA - Canada 143
BD - Bangladesh 141
JP - Giappone 117
PL - Polonia 75
AR - Argentina 72
NG - Nigeria 67
NL - Olanda 67
ZA - Sudafrica 65
BE - Belgio 58
CZ - Repubblica Ceca 58
ES - Italia 58
CH - Svizzera 50
IQ - Iraq 48
EU - Europa 31
AT - Austria 30
LT - Lituania 27
PK - Pakistan 27
UZ - Uzbekistan 26
EC - Ecuador 25
MA - Marocco 22
ID - Indonesia 21
AE - Emirati Arabi Uniti 19
AU - Australia 19
CO - Colombia 18
KE - Kenya 18
DZ - Algeria 17
JO - Giordania 17
PH - Filippine 16
CL - Cile 15
IL - Israele 15
MY - Malesia 15
NP - Nepal 15
PY - Paraguay 14
RO - Romania 14
SA - Arabia Saudita 14
EG - Egitto 12
VE - Venezuela 11
BG - Bulgaria 10
HU - Ungheria 10
JM - Giamaica 10
TN - Tunisia 10
KR - Corea 9
GR - Grecia 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
SM - San Marino 8
AZ - Azerbaigian 7
RS - Serbia 7
CR - Costa Rica 6
DK - Danimarca 6
LB - Libano 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
ET - Etiopia 5
HN - Honduras 5
KZ - Kazakistan 5
LU - Lussemburgo 5
MD - Moldavia 5
NO - Norvegia 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
GY - Guiana 4
KG - Kirghizistan 4
PA - Panama 4
AF - Afghanistan, Repubblica islamica di 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GD - Grenada 3
HR - Croazia 3
KW - Kuwait 3
NI - Nicaragua 3
PE - Perù 3
SR - Suriname 3
TL - Timor Orientale 3
TW - Taiwan 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
Totale 56.348
Città #
Milan 4.943
San Jose 2.300
Fairfield 2.129
Chandler 2.106
Jacksonville 2.081
Singapore 1.959
Ashburn 1.937
Woodbridge 1.696
Dallas 1.574
Hong Kong 1.098
Ann Arbor 1.077
Houston 1.037
Wilmington 922
Seattle 892
Cambridge 749
Izmir 725
Dublin 724
Princeton 718
Dearborn 655
Nyköping 610
Beijing 589
The Dalles 495
Dong Ket 445
Boardman 409
Rome 399
Chicago 379
Como 361
Lauterbourg 347
Council Bluffs 314
San Mateo 286
New York 283
Los Angeles 260
Ho Chi Minh City 220
Helsinki 191
Hanoi 172
San Diego 169
Santa Clara 163
London 143
Orem 143
Munich 137
Ogden 137
Tokyo 117
Mexico City 111
São Paulo 107
Guangzhou 91
Frankfurt am Main 87
Hefei 84
Washington 82
Chennai 81
Des Moines 72
Warsaw 69
Düsseldorf 67
Abuja 65
Denver 63
Nanjing 59
Atlanta 58
Montreal 58
Phoenix 58
Buffalo 54
Shanghai 54
Kunming 53
Norwalk 51
Varese 51
Verona 51
Brno 50
Brussels 48
Johannesburg 47
Redwood City 47
Stockholm 46
Brooklyn 44
Hangzhou 43
Poplar 43
Manchester 42
Amsterdam 39
Ponte Lambro 39
Zhengzhou 39
Berlin 36
Tianjin 36
Columbus 35
Rio de Janeiro 35
San Francisco 35
Da Nang 33
Jinan 33
Mountain View 33
Toronto 31
Brasília 29
Pune 28
Boston 27
Shenyang 27
Ankara 26
Mumbai 25
Auburn Hills 23
Belo Horizonte 23
Haiphong 23
Biên Hòa 21
Fuzhou 20
Paris 20
Philadelphia 20
Shenzhen 20
Tashkent 20
Totale 38.803
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.166
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals 448
Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia 272
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 267
Adrenergic modulation of migration, CD11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes 259
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 250
Adrenergic regulation of innate immunity: a review 248
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias 247
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment 246
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease 237
Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. 234
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 234
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 230
Adrenergic modulation of immune cells: an update 228
Isoflavone content and estrogenic activity of different batches of red clover (Trifolium pratense L.) extracts: An in vitro study in MCF-7 cells 227
An unusual systemic reaction associated with topical salicylic acid in a paediatric patient 226
Acetylcholine detection by a modified HPLC-ED method improves the assessment of cholinergic function in the myenteric plexus of the guinea-pig colon. 224
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 223
Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis 221
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines. 220
Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease 220
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease 220
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 219
The essential oil of bergamot stimulates reactive oxygen species production in human polymorphonuclear leukocytes 218
Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon. 217
7-hydroxymatairesinol potassium acetate (Hmr/LignanTM) from Norway spruce (Picea abies) knots and its active metabolite enterolactone exert estrogenic effects in the in MCF-7 cell model. 216
Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods 216
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients 215
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 213
Association between the circadian course of endogenous noradrenaline and the hematopoietic cell cycle in mouse bone marrow. 211
Dopaminergic D-1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes 211
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines 211
Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients 210
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? 209
Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignantrade mark) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. 207
Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells 206
Dopaminergic inhibition of human neutrophils is exerted through D1-like receptors and affected by bacterial infection 205
Scanning electron microscopy examination of endothelium morphology in human carotid plaques 203
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 201
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 201
Improved solubility and increased biological activity of NeoSol (TM) RCL40, a novel Red Clover Isoflavone Aglycones extract preparation 201
Are CYP1A2*1F and *1C associated with clozapine tolerability? A preliminary investigation 201
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors 199
Production of proinflammatory mediators by human neutrophils during long-term culture 199
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis 198
cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms 198
Clopidogrel pharmacogenetics: Associations between genotype and stent thrombosis risk in patients with stent placement 198
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 194
Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence 193
Levodopa-induced neutropenia 193
Gene expression of adhesion molecules in endothelial cells from patients with peripheral arterial disease is reduced after surgical revascularization and pharmacological treatment 192
Effects of a commercial product containing guaraná on psychological well-being, anxiety and mood: a single-blind, placebo-controlled study in healthy subjects 192
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 192
Calcium channel blockers and gastrointestinal motility: basic and clinical aspects 191
Modulation of enteric cholinergic neurons by hetero- and autoreceptors: cooperation among inhibitory inputs 190
Two patients with COMT inhibitor–induced hepatic dysfunction and UGT1A9 genetic polymorphism 189
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect 189
Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients 189
Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy. 188
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy 188
Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion: a study on human leukocytes. 187
Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells 187
Immunomodulatory activity of the lignan 7-hydroxymatairesinol potassium acetate (HMR/LignanTM) extracted from the heartwood of norway spruce (Picea abies) 186
Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes. 186
Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function 185
Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis 185
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors. 184
Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils 183
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 183
Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6 180
Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? 180
Dopamine, T cells and multiple sclerosis (MS) 180
Assessment of catecholamine content and metabolism in human pheripheral blood leukocytes subpopulation and leukemia cell lines 178
Adverse drug events in emergency department population: a prospective Italian study. 178
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study 178
HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines 177
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 177
Lack of relationship between cardiovascular reactivity to mental stress and autonomic modulation of the sinoatrial node in normotensive and hypertensive male subjects 176
Laminar pattern of mineral calcium-phosphorus deposits in a human carotid plaque: nanoscale ultrastructure and elemental analysis 176
Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study. 176
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 175
“Patterns” di deposito di calico-fosforo nelle placche carotidee nell’uomo. 175
A rapid and sensitive method to assay endogenous acetylcholine overflow from myenteric neurons by means of HPLC and electrochemical detection. 175
Studi sul ruolo di diversi sistemi recettoriali nella modulazione della liberazione di neurotrasmettitori dal plesso mienterico. 174
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 174
Functional interaction between presynaptic receptors modulating transmitter release in the Autonomic Nervous System. 173
Diazepam stimulates migration and phagocytosis of human neutrophils: Possible contribution of peripheral-type benzodiazepine receptors and intracellular calcium 173
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. 173
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 173
Simvastatin treatment in subjects at high cardiovascular risk modulates AT(1)R expression on circulating monocytes and T lymphocytes 172
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 172
Effects of carbamazepine on human PMN function: possible role of peripheral benzodiazepine receptors. 171
Adverse reaction to COMT inhibitors in Parkinson's disease patients: possible association with the UGTIA9 gene haplotype 171
Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies 171
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 170
Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. 168
Dietary supplement and drug use and doping knowledge and attitudes in italian young elite cyclists 168
Multiple sclerosis: Repurposing dopaminergic drugs for MS - The evidence mounts 168
Produzione di Tumor Necrosis Factor-a; e Interleuchina-4 dai linfociti circolanti e di Interleuchina-8 dai neutrofili in pazienti con sindrome delle apnee notturne: variazioni durante terapia notturna con pressione continua positiva nelle vie aeree. 167
β 2 -Adrenoceptors inhibit neutrophil extracellular traps in human polymorphonuclear leukocytes 167
Totale 21.062
Categoria #
all - tutte 219.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021848 0 0 0 0 0 0 0 0 0 0 0 848
2021/20224.066 377 456 383 578 198 186 152 203 194 514 314 511
2022/20235.478 499 372 456 636 353 1.164 29 741 732 175 209 112
2023/20247.971 1.238 1.189 1.278 1.519 1.497 586 42 170 216 66 49 121
2024/20255.474 64 103 1.054 156 157 279 284 446 524 455 508 1.444
2025/202614.730 1.097 1.033 1.248 1.890 1.450 881 2.925 925 1.436 970 575 300
Totale 56.667